Ye Myint Aung
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ye Myint Aung has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Declan Walsh
Department of Supportive Oncology, Levine Cancer Institute, Atrium Health, Charlotte, USA
2 shared publicationsJake Waldman
Department of Supportive Oncology, Levine Cancer Institute, Atrium Health, Charlotte, USA
2 shared publicationsAynur Aktas
Supportive Oncology, Levine Cancer Institute, Charlotte, North Carolina, USA
1 shared publication- Aynur Aktas
Department of Supportive Oncology Levine Cancer Institute, Atrium Health Charlotte North Carolina USA
1 shared publication Beth York
Department of Supportive Oncology, Levine Cancer Institute, Atrium Health, Charlotte, USA
1 shared publication- Declan Walsh
Levin Cancer, Atrium Health Levine Cancer Institute, Charlotte, North Carolina, USA
1 shared publication
Latest Publications
- 23 June 2025
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (7) , 1-7
The supportive oncology landscape: current status
Purpose Cancer care has changed dramatically in the past decade, with novel treatments and longer life expectancy. Despite these advancements, many people with cancer experience significant disease and treatment-related morbidity and mortality. The term “supportive oncology” has been proposed to define various services (nutrition counseling, palliative medicine, psychology, etc.) to support individuals throughout the cancer-care continuum. Though these services are vital, their availability, implementation, and organization are inconsistent and ill-defined. Methods We did a Google™ search to identify the availability of sixteen empirically determined supportive oncology services. Four distinct searches were performed sequentially with the terms, 1.) “supportive oncology programs”, 2.) “supportive oncology departments”, 3.) “cancer care support”, and 4.) “cancer support programs.” Results were filtered through ten further criteria. Descriptive language regarding service organization and leadership structure was reviewed. Results All four searches in combination yielded 88 cancer care entities (CCE). Then, 32 (36%) were designated by the National Cancer Institute as a Comprehensive Cancer Center (NCI-CCC). Of all CCE, the most frequent service provided was support groups (76/88, 86%), and least often geriatric oncology (18/88, 21%). NCI-CCC offered a greater scope and scale of services than non-designated centers. Then, 45 (51%) CCE referred to these offerings as “services” but only 8 (9%) were organized as a formal department. Conclusions Heterogeneity exists in the types of supportive services provided by CCE. The predominant informal organization of supportive oncology services is notable and unsatisfactory. To improve comprehensive cancer care, there is a compelling need for organizations like the NCI, American Society of Clinical Oncology, and the Commission on Cancer to develop formal standards for supportive oncology services.
- 23 June 2025
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 33 (7) , 1-7
The supportive oncology landscape: current status
Purpose Cancer care has changed dramatically in the past decade, with novel treatments and longer life expectancy. Despite these advancements, many people with cancer experience significant disease and treatment-related morbidity and mortality. The term “supportive oncology” has been proposed to define various services (nutrition counseling, palliative medicine, psychology, etc.) to support individuals throughout the cancer-care continuum. Though these services are vital, their availability, implementation, and organization are inconsistent and ill-defined. Methods We did a Google™ search to identify the availability of sixteen empirically determined supportive oncology services. Four distinct searches were performed sequentially with the terms, 1.) “supportive oncology programs”, 2.) “supportive oncology departments”, 3.) “cancer care support”, and 4.) “cancer support programs.” Results were filtered through ten further criteria. Descriptive language regarding service organization and leadership structure was reviewed. Results All four searches in combination yielded 88 cancer care entities (CCE). Then, 32 (36%) were designated by the National Cancer Institute as a Comprehensive Cancer Center (NCI-CCC). Of all CCE, the most frequent service provided was support groups (76/88, 86%), and least often geriatric oncology (18/88, 21%). NCI-CCC offered a greater scope and scale of services than non-designated centers. Then, 45 (51%) CCE referred to these offerings as “services” but only 8 (9%) were organized as a formal department. Conclusions Heterogeneity exists in the types of supportive services provided by CCE. The predominant informal organization of supportive oncology services is notable and unsatisfactory. To improve comprehensive cancer care, there is a compelling need for organizations like the NCI, American Society of Clinical Oncology, and the Commission on Cancer to develop formal standards for supportive oncology services.
- 25 February 2025
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 69 (5) , e417-e419
Outpatient Palliative Medicine: A Synopsis of Recent Clinically Important Publications
- 25 February 2025
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 69 (5) , e417-e419
Outpatient Palliative Medicine: A Synopsis of Recent Clinically Important Publications
- 15 January 2025
- Published by BMJ in BMJ Supportive & Palliative Care
Malnutrition risk and overall survival at solid tumour diagnosis
Purpose Malnutrition severely impacts tolerance to anticancer therapies, but any relationship with overall survival (OS) at the time of solid tumour diagnosis in outpatients in the USA remains unclear. Methods This retrospective study evaluated 3562 patients who completed the Malnutrition Screening Tool (MST) at diagnosis, identifying the relationship between MST risk, a validated tool evaluating anorexia and weight loss, and OS. MST score of ≥2 of 5 was classified as high malnutrition risk (H-MST). Kaplan-Meier techniques and Cox proportional hazards models were used to analyse OS in H-MST versus low malnutrition risk (L-MST). Results In the unadjusted models, MST risk was individually associated with OS. Multivariable regression confirmed that MST risk remained independently prognostic for OS after controlling for key confounding variables, HR=1.51 (95% CI: 1.33 to 1.72). The H-MST group had shorter OS (50-month survival rates: 69% L-MST vs 60% H-MST). Conclusion MST risk at diagnosis is an independent prognostic factor for OS. H-MST risk is associated with shorter survival in a broad cohort of solid tumour oncology outpatients.
- 15 January 2025
- Published by BMJ in BMJ Supportive & Palliative Care
Malnutrition risk and overall survival at solid tumour diagnosis
Purpose Malnutrition severely impacts tolerance to anticancer therapies, but any relationship with overall survival (OS) at the time of solid tumour diagnosis in outpatients in the USA remains unclear. Methods This retrospective study evaluated 3562 patients who completed the Malnutrition Screening Tool (MST) at diagnosis, identifying the relationship between MST risk, a validated tool evaluating anorexia and weight loss, and OS. MST score of ≥2 of 5 was classified as high malnutrition risk (H-MST). Kaplan-Meier techniques and Cox proportional hazards models were used to analyse OS in H-MST versus low malnutrition risk (L-MST). Results In the unadjusted models, MST risk was individually associated with OS. Multivariable regression confirmed that MST risk remained independently prognostic for OS after controlling for key confounding variables, HR=1.51 (95% CI: 1.33 to 1.72). The H-MST group had shorter OS (50-month survival rates: 69% L-MST vs 60% H-MST). Conclusion MST risk at diagnosis is an independent prognostic factor for OS. H-MST risk is associated with shorter survival in a broad cohort of solid tumour oncology outpatients.
- 8 November 2023
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 15 (6) , 731-732
Nutrition assessment defects in cancer clinical trials
- 8 November 2023
- Published by BMJ in BMJ Supportive & Palliative Care
- Vol. 15 (6) , 731-732
Nutrition assessment defects in cancer clinical trials